カテゴリー： Market Monitor Global, 世界, 医療/バイオ

ブリナツモマブの世界市場見通し2023年-2029年

◆英語タイトル：Blinatumomab Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5722）

◆商品コード：MMG23JU5722
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：71
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Blinatumomab Market 調査レポートは次の情報を含め、グローバルにおけるのブリナツモマブ市場規模と予測を収録しています。・世界のブリナツモマブ市場：売上、2018年-2023年、2024年-2029年
・世界のブリナツモマブ市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のブリナツモマブ市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「プレフィルド式」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

ブリナツモマブのグローバル主要企業は、Amgenなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、ブリナツモマブのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のブリナツモマブ市場：タイプ別、2018年-2023年、2024年-2029年
世界のブリナツモマブ市場：タイプ別市場シェア、2022年
・プレフィルド式、ノンプレフィルド式

世界のブリナツモマブ市場：用途別、2018年-2023年、2024年-2029年
世界のブリナツモマブ市場：用途別市場シェア、2022年
・病院、薬局

世界のブリナツモマブ市場：地域・国別、2018年-2023年、2024年-2029年
世界のブリナツモマブ市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるブリナツモマブのグローバル売上、2018年-2023年
・主要企業におけるブリナツモマブのグローバル売上シェア、2022年
・主要企業におけるブリナツモマブのグローバル販売量、2018年-2023年
・主要企業におけるブリナツモマブのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Amgen

*************************************************************

・調査・分析レポートの概要
ブリナツモマブ市場の定義
市場セグメント
世界のブリナツモマブ市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のブリナツモマブ市場規模
世界のブリナツモマブ市場規模：2022年 VS 2029年
世界のブリナツモマブ市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのブリナツモマブの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のブリナツモマブ製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：プレフィルド式、ノンプレフィルド式
ブリナツモマブのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、薬局
ブリナツモマブの用途別グローバル売上・予測

・地域別市場分析
地域別ブリナツモマブ市場規模 2022年と2029年
地域別ブリナツモマブ売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Amgen
...

Blinatumomab (trade name Blincyto) is a biopharmaceutical drug used as a second-line treatment for Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia.
This report aims to provide a comprehensive presentation of the global market for Blinatumomab, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blinatumomab. This report contains market size and forecasts of Blinatumomab in global, including the following market information:
Global Blinatumomab Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Blinatumomab Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Blinatumomab companies in 2022 (%)
The global Blinatumomab market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Prefilled Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Blinatumomab include Amgen. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Blinatumomab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Blinatumomab Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Blinatumomab Market Segment Percentages, by Type, 2022 (%)
Prefilled
Non-prefilled
Global Blinatumomab Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Blinatumomab Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Global Blinatumomab Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Blinatumomab Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Blinatumomab revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Blinatumomab revenues share in global market, 2022 (%)
Key companies Blinatumomab sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Blinatumomab sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Blinatumomab, market overview.
Chapter 2: Global Blinatumomab market size in revenue and volume.
Chapter 3: Detailed analysis of Blinatumomab manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Blinatumomab in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Blinatumomab capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Blinatumomab Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Blinatumomab Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Blinatumomab Overall Market Size
2.1 Global Blinatumomab Market Size: 2022 VS 2029
2.2 Global Blinatumomab Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Blinatumomab Sales: 2018-2029
3 Company Landscape
3.1 Top Blinatumomab Players in Global Market
3.2 Top Global Blinatumomab Companies Ranked by Revenue
3.3 Global Blinatumomab Revenue by Companies
3.4 Global Blinatumomab Sales by Companies
3.5 Global Blinatumomab Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Blinatumomab Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Blinatumomab Product Type
3.8 Tier 1, Tier 2 and Tier 3 Blinatumomab Players in Global Market
3.8.1 List of Global Tier 1 Blinatumomab Companies
3.8.2 List of Global Tier 2 and Tier 3 Blinatumomab Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Blinatumomab Market Size Markets, 2022 & 2029
4.1.2 Prefilled
4.1.3 Non-prefilled
4.2 By Type – Global Blinatumomab Revenue & Forecasts
4.2.1 By Type – Global Blinatumomab Revenue, 2018-2023
4.2.2 By Type – Global Blinatumomab Revenue, 2024-2029
4.2.3 By Type – Global Blinatumomab Revenue Market Share, 2018-2029
4.3 By Type – Global Blinatumomab Sales & Forecasts
4.3.1 By Type – Global Blinatumomab Sales, 2018-2023
4.3.2 By Type – Global Blinatumomab Sales, 2024-2029
4.3.3 By Type – Global Blinatumomab Sales Market Share, 2018-2029
4.4 By Type – Global Blinatumomab Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Blinatumomab Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application – Global Blinatumomab Revenue & Forecasts
5.2.1 By Application – Global Blinatumomab Revenue, 2018-2023
5.2.2 By Application – Global Blinatumomab Revenue, 2024-2029
5.2.3 By Application – Global Blinatumomab Revenue Market Share, 2018-2029
5.3 By Application – Global Blinatumomab Sales & Forecasts
5.3.1 By Application – Global Blinatumomab Sales, 2018-2023
5.3.2 By Application – Global Blinatumomab Sales, 2024-2029
5.3.3 By Application – Global Blinatumomab Sales Market Share, 2018-2029
5.4 By Application – Global Blinatumomab Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Blinatumomab Market Size, 2022 & 2029
6.2 By Region – Global Blinatumomab Revenue & Forecasts
6.2.1 By Region – Global Blinatumomab Revenue, 2018-2023
6.2.2 By Region – Global Blinatumomab Revenue, 2024-2029
6.2.3 By Region – Global Blinatumomab Revenue Market Share, 2018-2029
6.3 By Region – Global Blinatumomab Sales & Forecasts
6.3.1 By Region – Global Blinatumomab Sales, 2018-2023
6.3.2 By Region – Global Blinatumomab Sales, 2024-2029
6.3.3 By Region – Global Blinatumomab Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Blinatumomab Revenue, 2018-2029
6.4.2 By Country – North America Blinatumomab Sales, 2018-2029
6.4.3 US Blinatumomab Market Size, 2018-2029
6.4.4 Canada Blinatumomab Market Size, 2018-2029
6.4.5 Mexico Blinatumomab Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Blinatumomab Revenue, 2018-2029
6.5.2 By Country – Europe Blinatumomab Sales, 2018-2029
6.5.3 Germany Blinatumomab Market Size, 2018-2029
6.5.4 France Blinatumomab Market Size, 2018-2029
6.5.5 U.K. Blinatumomab Market Size, 2018-2029
6.5.6 Italy Blinatumomab Market Size, 2018-2029
6.5.7 Russia Blinatumomab Market Size, 2018-2029
6.5.8 Nordic Countries Blinatumomab Market Size, 2018-2029
6.5.9 Benelux Blinatumomab Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Blinatumomab Revenue, 2018-2029
6.6.2 By Region – Asia Blinatumomab Sales, 2018-2029
6.6.3 China Blinatumomab Market Size, 2018-2029
6.6.4 Japan Blinatumomab Market Size, 2018-2029
6.6.5 South Korea Blinatumomab Market Size, 2018-2029
6.6.6 Southeast Asia Blinatumomab Market Size, 2018-2029
6.6.7 India Blinatumomab Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Blinatumomab Revenue, 2018-2029
6.7.2 By Country – South America Blinatumomab Sales, 2018-2029
6.7.3 Brazil Blinatumomab Market Size, 2018-2029
6.7.4 Argentina Blinatumomab Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Blinatumomab Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Blinatumomab Sales, 2018-2029
6.8.3 Turkey Blinatumomab Market Size, 2018-2029
6.8.4 Israel Blinatumomab Market Size, 2018-2029
6.8.5 Saudi Arabia Blinatumomab Market Size, 2018-2029
6.8.6 UAE Blinatumomab Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Blinatumomab Major Product Offerings
7.1.4 Amgen Blinatumomab Sales and Revenue in Global (2018-2023)
7.1.5 Amgen Key News & Latest Developments
8 Global Blinatumomab Production Capacity, Analysis
8.1 Global Blinatumomab Production Capacity, 2018-2029
8.2 Blinatumomab Production Capacity of Key Manufacturers in Global Market
8.3 Global Blinatumomab Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Blinatumomab Supply Chain Analysis
10.1 Blinatumomab Industry Value Chain
10.2 Blinatumomab Upstream Market
10.3 Blinatumomab Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Blinatumomab Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Blinatumomab in Global Market
Table 2. Top Blinatumomab Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Blinatumomab Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Blinatumomab Revenue Share by Companies, 2018-2023
Table 5. Global Blinatumomab Sales by Companies, (K Units), 2018-2023
Table 6. Global Blinatumomab Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Blinatumomab Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Blinatumomab Product Type
Table 9. List of Global Tier 1 Blinatumomab Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Blinatumomab Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Blinatumomab Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Blinatumomab Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Blinatumomab Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Blinatumomab Sales (K Units), 2018-2023
Table 15. By Type - Global Blinatumomab Sales (K Units), 2024-2029
Table 16. By Application – Global Blinatumomab Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Blinatumomab Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Blinatumomab Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Blinatumomab Sales (K Units), 2018-2023
Table 20. By Application - Global Blinatumomab Sales (K Units), 2024-2029
Table 21. By Region – Global Blinatumomab Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Blinatumomab Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Blinatumomab Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Blinatumomab Sales (K Units), 2018-2023
Table 25. By Region - Global Blinatumomab Sales (K Units), 2024-2029
Table 26. By Country - North America Blinatumomab Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Blinatumomab Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Blinatumomab Sales, (K Units), 2018-2023
Table 29. By Country - North America Blinatumomab Sales, (K Units), 2024-2029
Table 30. By Country - Europe Blinatumomab Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Blinatumomab Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Blinatumomab Sales, (K Units), 2018-2023
Table 33. By Country - Europe Blinatumomab Sales, (K Units), 2024-2029
Table 34. By Region - Asia Blinatumomab Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Blinatumomab Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Blinatumomab Sales, (K Units), 2018-2023
Table 37. By Region - Asia Blinatumomab Sales, (K Units), 2024-2029
Table 38. By Country - South America Blinatumomab Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Blinatumomab Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Blinatumomab Sales, (K Units), 2018-2023
Table 41. By Country - South America Blinatumomab Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Blinatumomab Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Blinatumomab Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Blinatumomab Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Blinatumomab Sales, (K Units), 2024-2029
Table 46. Amgen Company Summary
Table 47. Amgen Blinatumomab Product Offerings
Table 48. Amgen Blinatumomab Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Amgen Key News & Latest Developments
Table 50. Blinatumomab Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 51. Global Blinatumomab Capacity Market Share of Key Manufacturers, 2021-2023
Table 52. Global Blinatumomab Production by Region, 2018-2023 (K Units)
Table 53. Global Blinatumomab Production by Region, 2024-2029 (K Units)
Table 54. Blinatumomab Market Opportunities & Trends in Global Market
Table 55. Blinatumomab Market Drivers in Global Market
Table 56. Blinatumomab Market Restraints in Global Market
Table 57. Blinatumomab Raw Materials
Table 58. Blinatumomab Raw Materials Suppliers in Global Market
Table 59. Typical Blinatumomab Downstream
Table 60. Blinatumomab Downstream Clients in Global Market
Table 61. Blinatumomab Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Blinatumomab Segment by Type in 2022
Figure 2. Blinatumomab Segment by Application in 2022
Figure 3. Global Blinatumomab Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Blinatumomab Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Blinatumomab Revenue, 2018-2029 (US$, Mn)
Figure 7. Blinatumomab Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Blinatumomab Revenue in 2022
Figure 9. By Type - Global Blinatumomab Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Blinatumomab Revenue Market Share, 2018-2029
Figure 11. By Type - Global Blinatumomab Sales Market Share, 2018-2029
Figure 12. By Type - Global Blinatumomab Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Blinatumomab Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Blinatumomab Revenue Market Share, 2018-2029
Figure 15. By Application - Global Blinatumomab Sales Market Share, 2018-2029
Figure 16. By Application - Global Blinatumomab Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Blinatumomab Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Blinatumomab Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Blinatumomab Revenue Market Share, 2018-2029
Figure 20. By Region - Global Blinatumomab Sales Market Share, 2018-2029
Figure 21. By Country - North America Blinatumomab Revenue Market Share, 2018-2029
Figure 22. By Country - North America Blinatumomab Sales Market Share, 2018-2029
Figure 23. US Blinatumomab Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Blinatumomab Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Blinatumomab Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Blinatumomab Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Blinatumomab Sales Market Share, 2018-2029
Figure 28. Germany Blinatumomab Revenue, (US$, Mn), 2018-2029
Figure 29. France Blinatumomab Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Blinatumomab Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Blinatumomab Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Blinatumomab Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Blinatumomab Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Blinatumomab Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Blinatumomab Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Blinatumomab Sales Market Share, 2018-2029
Figure 37. China Blinatumomab Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Blinatumomab Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Blinatumomab Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Blinatumomab Revenue, (US$, Mn), 2018-2029
Figure 41. India Blinatumomab Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Blinatumomab Revenue Market Share, 2018-2029
Figure 43. By Country - South America Blinatumomab Sales Market Share, 2018-2029
Figure 44. Brazil Blinatumomab Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Blinatumomab Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Blinatumomab Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Blinatumomab Sales Market Share, 2018-2029
Figure 48. Turkey Blinatumomab Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Blinatumomab Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Blinatumomab Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Blinatumomab Revenue, (US$, Mn), 2018-2029
Figure 52. Global Blinatumomab Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Blinatumomab by Region, 2022 VS 2029
Figure 54. Blinatumomab Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ブリナツモマブの世界市場見通し2023年-2029年(Blinatumomab Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

ブリナツモマブの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp